References
- Jeunemaitre X., Menard J., Clauser E., Corvol P. Angiotensinogen: Molecular Biology and Genetics. Hypertension: Pathophysiology, Diagnosis and Management, J. H. Laragh, M. B. Brenner. Raven Press Ltd, New York 1995; 1653–1665
- Laragh J. H., Sealey J. E. Renin-angiotensin aldosterone system and the renal regulation of sodium, potassium, and blood pressure homeostasis. Handbook of Physiology. Section 8th. Renal Physiology, E. E. Windhager. Oxford University Press, New York 1992; 1409–1541.
- Rasmussen S., Nielsen M. D., Giese J. Captopril combined with thiazide lowers renin substrate concentration: implication for methodology on renin assays. Clin Sci. 1981; 60: 591–593
- Hilgenfeldt U., Schwind S. Changes in the renin-angiotensin system after nephrectomy and adrenalectomy. J Steroid Biochem Mol Biol. 1993; 45: 41–47.
- Freeman R. H., Rostorfer H. H. Hepatic changes in renin substrate biosynthesis and alkaline phosphatase activity in the rat. Am J Physiol. 1972; 223: 364–370
- Dzau V. J., Herrmann H. C. Hormonal control of angiotensinogen production. Life Sci. 1982; 30: 577–584
- Cumin F., Le-N'guyen D., Castro B., Menard J., Corvol P. Comparative enzymatic studies on human renin activity on pure natural or synthetic substrates. Biochem Biophys Acta. 1987; 913: 10–19
- Poulsen K. Kinetics of the renin system: the basis for determination of the different components of the system. Scand J Clin Lab Invest. 1973; 31: 3–80
- Okamoto H., Ohashi Y., Itoh N. Involvement of leukocyte and glucocorticoid in the acute-phase response of angiotensinogen. Biochem Biophys Res Commun. 1987; 145: 1225–1230
- Sernia C., Clements J. A., Funder J. F. Regulation of liver angiotensinogen mRNA by glucocorticoids and thyroxine. Mol Cell Endocrinol. 1989; 61: 147–156
- Klett C., Ganten D., Hellmann W., Kaling M., Ryffel G. U., Weimar-Ehl T., Hackenthal E. Regulation of hepatic angiotensinogen synthesis and secretion by steroid hormones. Endocrinology. 1992; 130: 3660–3668
- Bouhnik J., Galen F. X., Clauser E., Menard J., Corvol P. The renin-angiotensin system in thyroidectomized rats. Endocrinology. 1981; 108: 647–650
- Kimura S., Iwao H., Fukui K., Abe Y., Tanaka S. Effects of thyroid hormone on angiotensinogen and renin messenger RNA levels in rats. Jpn J Pharmacol. 1990; 52: 281–285
- Hackenthal E., Klett C. Angiotensin II and dexamethasone regulate angiotensinogen mRNA by different mechanisms. J Steroid Biochem Mol Biol. 1993; 45: 33–40
- Iwao H., Kimura S., Fukui K., Nakamura A., Tamaki T., Okhubo H., Nakanishi S., Abe Y. Elevated angiotensinogen mRNA levels in rat liver by nephrectomy. Am J Physiol. 1990; 258: E413–E417
- Voigt J., Koster H. Induction of plasma proangiotensin by steroid hormones in nephrectomized rats. Eur J Pharmacol. 1980; 110: 57–65
- Radziwill R., Stuzmann M., Hilgenfeldt U., Hackenthal E. Converting enzyme inhibitor-induced changes of plasma angiotensinogen concentration in the rat. Eur J Pharmacol. 1986; 122: 59–64
- Kokubu T., Ueda E., Ono M., Kawabe T., Hayashi Y., Kan T. Effects of captopril (SQ 14,225) on the renin-angiotensin-aldosterone system in normal rats. Eur J Pharmacol. 1980; 62: 269–275
- Iwao H., Fukui K., Kim S., Nakayama K., Ohkubo H., Nakanishi S., Abe Y. Sodium balance effects on renin, angiotensinogen, and atrial natriuretic polypeptide mRNA levels. Am J Physiol. 1988; 255: E129–E136
- Nakamura A., Iwao H., Fukui K., Kimura S., Tamaki T., Abe Y. Effect of angiotensin II on angiotensinogen production in adrenalectomized rats. Life Sci. 1990; 46: 1657–1660
- Clauser E., Bouhnik J., Jaramillo H. N., Auzan C., Corvol P., Menard J. Angiotensinogen production and consumption in adrenalectomized rats. Endocrinology 1985; 116: 274–280
- Voigt J., Koster H. Immunochemical studies on biosynthesis of rat plasma angiotensinogen and its regulation by cortisol. Biochim Biophys Acta. 1985; 842: 100–107
- Glassock R. J., Cohen A. H., Adler S. G. Primary glomerular diseases, The Kidney, M. B. Brenner. Saunders Company, Philadelphia, W.B. 1996; vol 2: 1392–1497.
- Wheeler D. C., Bernard D. B. Lipid abnormalities in nephrotic syndrome: causes, consequences and treatment. Am J Kidney Dis. 1994; 23: 331–346
- Pedraza-Chaverrí J., Cruz C., Ibarra-Rubio M. E., Chávez M. T., Calleja C., Tapia E., Uribe M. C., Romero L., Peña J. C. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in ratsI. The role of proteinuria, hypoproteinemia and renin-angiotensin-aldosterone system on sodium retention. Rev Invest Clin. 1990; 42: 29–38
- Yayama K., Konishi K., Ohta A., Takano M., Ohtani R., Itoh N., Okamoto H. Elevation of plasma angiotensinogen in rats with experimentally induced nephrosis. Nephron. 1993; 63: 89–93
- Pedraza-Chaverrí J., Cruz C., Ibarra-Rubio M. E., Hernández C., Tapia E., Peña J. C. Urinary excretion of renin and angiotensinogen in nephrotic rats. Nephron. 1991; 57: 106–108
- Pedraza-Chaverrí J., Cruz C., Chávez M. T., Ibarra-Rubio M. E., Tapia E., Peña J. C. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in ratsIII. Effect of captopril, an angiotensin I converting enzyme inhibitor, on proteinuria and sodium retention. Rev Invest Clin. 1990; 42: 210–216
- Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Bio Techniques. 1993; 15: 532–536
- Lynch K. R., Simnad V. I., Ben-Ari E. T., Garrison J. C. Localization of preangiotensinogen messenger RNA sequences in the rat brain. Hypertension. 1986; 8: 540–543
- Szokol M., Soltész M. B., Nagy A., Lengyel Z., Gomba S. Z. The effect of adrenalectomy on proteinuria of spontaneously hypertensive rats and normotensive controls. Exp Pathol. 1986; 30: 233–242
- Lewandowsky A. E., Liao W. S.L., Stinson-Fisher C. A., Kent J. D., Jefferson L. S. Effects of experimentally induced nephrosis on protein synthesis in the liver. Am J Physiol. 1988; 254: C634–C642
- Sun X., Martin V., Weiss R. H., Kaysen G. A. Selective transcriptional augmentation of hepatic gene expression in the rat with Heymann nephritis. Am J Physiol. 1993; 264: F441–F447
- Ibarra-Rubio M. E., Pedraza-Chaverrí J., Panduro A. Differential regulation in the expression of hepatic genes in nephrotic and pair-fed rats. Nephron. 1993; 65: 119–124
- Ludwing G., Suzuki F., Murakami K., Ganten D., Hackenthal E. Kidney renin mRNA, renin secretion and plasma renin following adrenalectomy, salt depletion or enalapril treatment in the rat. J Hypertens. 1986; 4: S431–S433
- Tateishi H., Nasjletti A., Masson G. M.C. Role of renin in the regulation of angiotensinogen levels in plasma. Proc Soc Exp Biol Med. 1971; 137: 1424–1428
- Klett C., Hellmann W., Hackenthal E., Ganten D. Modulation of tissue angiotensinogen gene expression by glucocorticoids, estrogens, and androgens in SHR and WKY rats. Clin Exp Hypertens. 1993; 15: 683–708
- Pratt R. E., Zou W. M., Naftilan A. J., Ingelfinger J. R., Dzau V. J. Altered sodium regulation of renal angiotensinogen mRNA in the spontaneously hypertensive rat. Am J Physiol. 1989; 256: F469–F474
- Yayama K., Yoshiya M., Takahashi K., Matsui T., Takano M., Okamoto H. Role of the kidney in the plasma clearance of angiotensinogen in the rat: plasma clearance and tissue distribution of 125l-angiotensinogen. Life Sci. 1995; 57: 1791–1801
- Pedraza-Chaverrí J., Cruz C., Sandoval A. A., Tapia E., Peña J. C. Effects of captopril on urinary excretion of renin and angiotensinogen in aminonucleoside nephrosis. Ren Fail. 1992; 14: 155–159
- Olson J. L., Rennke H. G., Venkatachalam M. A. Alterations in the charge and size selectivity barrier of the glomerular filter in aminonucleoside nephrosis in rats. Lab Invest. 1981; 44: 271–279